Location History:
- Sint Martens Latem, BE (2017 - 2022)
- St. Martens-Latem, BE (2014 - 2023)
- St. Martens-Lataem, BE (2024)
Company Filing History:
12 out of 163 
5 out of 1,451 
Years Active: 2014-2025
Title: The Innovative Genius of Sigrid Cornelis
Introduction
Sigrid Cornelis, an accomplished inventor based in Sint Martens Latem, Belgium, has made significant strides in the field of biotechnology. With a total of 12 patents to her name, she has positioned herself as a leader in developing novel therapeutics for treating inflammatory and autoimmune diseases. Her work is characterized by a focus on immunoglobulin single variable domains that target crucial cytokines implicated in these diseases.
Latest Patents
Sigrid Cornelis's recent patents reflect her dedication to addressing critical health challenges. One of her notable inventions is related to "Nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP." This technology aims to provide a novel type of drug for individuals suffering from inflammatory diseases. The polypeptides developed consist of at least four immunoglobulin single variable domains (ISVDs), with at least two binding to IL-13 and two binding to TSLP. This innovative approach also includes the development of nucleic acids, vectors, and compositions essential for drug formulation.
Another important patent speaks to her contribution to treating inflammatory and autoimmune diseases, particularly rheumatoid arthritis. This patent provides "Polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-α." The formulation includes at least three ISVDs, with one binding to TNF-α and two binding to IL-6. This discovery is a promising step forward in drug development for those suffering from such debilitating conditions.
Career Highlights
Throughout her career, Sigrid Cornelis has been affiliated with prominent companies, including Ablynx N.V. and Sanofi. Her work in these organizations has enhanced her reputation in the research and development landscape of biotechnology. Her contributions have been instrumental in advancing therapeutic solutions, showcasing her skills and dedication to innovation.
Collaborations
Collaboration has been a significant aspect of Sigrid's career. She has worked alongside notable colleagues such as Heidi Rommelaere and Ann Brigé. These partnerships have enriched her research endeavors and led to the development of groundbreaking patents that address pressing health concerns.
Conclusion
Sigrid Cornelis is a trailblazer in the field of biotechnology, with an impressive portfolio of patents that pave the way for new therapeutic approaches. Her work focusing on immunoglobulin single variable domains holds substantial promise for treating inflammatory and autoimmune diseases. As she continues her innovative journey, the impact of her contributions will undoubtedly shape the future of medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.